Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease
The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans. The COVID-19 pandemic has had a profound imp...
Gespeichert in:
| Veröffentlicht in: | Neuron (Cambridge, Mass.) Mass.), 2021-10, Vol.109 (20), p.3199-3202 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3202 |
|---|---|
| container_issue | 20 |
| container_start_page | 3199 |
| container_title | Neuron (Cambridge, Mass.) |
| container_volume | 109 |
| creator | Snider, B. Joy Holtzman, David M. |
| description | The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.
The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, Snider and Holtzman discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans. |
| doi_str_mv | 10.1016/j.neuron.2021.08.026 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2573438309</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0896627321006231</els_id><sourcerecordid>2573438309</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-67db0cb9d50a177200c8b04bf7918b3bb9e0b2f26c5c92f419d1159939ec97ba3</originalsourceid><addsrcrecordid>eNp9kM9OGzEQh62qSE2BN-jBx152GXv_uodKKA0tUiQuwNWyvePgaNdO7U1FOPEAvEBfjydh0yB64zSa0Te_0XyEfGGQM2D12Tr3uI3B5xw4y6HNgdcfyIyBaLKSCfGRzKAVdVbzpvhEPqe0BmBlJdiMPC2sRTMmGiydX91e_siYoMHTTUTTO--M6qnyHX1rIiZU0dxR5-m_q31Y7b7Rxb0aNj0mamMY_kPhFepwhR6jGt002eed9w936AaMz49_E-3cxCc8IUdW9QlPX-sxublYXM9_Zcurn5fz82VmirYas7rpNBgtugoUaxoOYFoNpbaNYK0utBYImltem8oIbicDHWOVEIVAIxqtimPy9ZC7ieH3FtMoB5cM9r3yGLZJ8qopyqItQExoeUBNDClFtHIT3aDiTjKQe_lyLQ_y5V6-hFZO8qe174c1nN744zDKZBx6g52bxI6yC-79gBfwO5KI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2573438309</pqid></control><display><type>article</type><title>Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease</title><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Snider, B. Joy ; Holtzman, David M.</creator><creatorcontrib>Snider, B. Joy ; Holtzman, David M.</creatorcontrib><description>The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.
The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, Snider and Holtzman discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.</description><identifier>ISSN: 0896-6273</identifier><identifier>EISSN: 1097-4199</identifier><identifier>DOI: 10.1016/j.neuron.2021.08.026</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Alzheimer’s disease ; clinical trials ; COVID-19 ; translational neuroscience</subject><ispartof>Neuron (Cambridge, Mass.), 2021-10, Vol.109 (20), p.3199-3202</ispartof><rights>2021 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-67db0cb9d50a177200c8b04bf7918b3bb9e0b2f26c5c92f419d1159939ec97ba3</citedby><cites>FETCH-LOGICAL-c385t-67db0cb9d50a177200c8b04bf7918b3bb9e0b2f26c5c92f419d1159939ec97ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0896627321006231$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Snider, B. Joy</creatorcontrib><creatorcontrib>Holtzman, David M.</creatorcontrib><title>Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease</title><title>Neuron (Cambridge, Mass.)</title><description>The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.
The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, Snider and Holtzman discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.</description><subject>Alzheimer’s disease</subject><subject>clinical trials</subject><subject>COVID-19</subject><subject>translational neuroscience</subject><issn>0896-6273</issn><issn>1097-4199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM9OGzEQh62qSE2BN-jBx152GXv_uodKKA0tUiQuwNWyvePgaNdO7U1FOPEAvEBfjydh0yB64zSa0Te_0XyEfGGQM2D12Tr3uI3B5xw4y6HNgdcfyIyBaLKSCfGRzKAVdVbzpvhEPqe0BmBlJdiMPC2sRTMmGiydX91e_siYoMHTTUTTO--M6qnyHX1rIiZU0dxR5-m_q31Y7b7Rxb0aNj0mamMY_kPhFepwhR6jGt002eed9w936AaMz49_E-3cxCc8IUdW9QlPX-sxublYXM9_Zcurn5fz82VmirYas7rpNBgtugoUaxoOYFoNpbaNYK0utBYImltem8oIbicDHWOVEIVAIxqtimPy9ZC7ieH3FtMoB5cM9r3yGLZJ8qopyqItQExoeUBNDClFtHIT3aDiTjKQe_lyLQ_y5V6-hFZO8qe174c1nN744zDKZBx6g52bxI6yC-79gBfwO5KI</recordid><startdate>20211020</startdate><enddate>20211020</enddate><creator>Snider, B. Joy</creator><creator>Holtzman, David M.</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20211020</creationdate><title>Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease</title><author>Snider, B. Joy ; Holtzman, David M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-67db0cb9d50a177200c8b04bf7918b3bb9e0b2f26c5c92f419d1159939ec97ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alzheimer’s disease</topic><topic>clinical trials</topic><topic>COVID-19</topic><topic>translational neuroscience</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Snider, B. Joy</creatorcontrib><creatorcontrib>Holtzman, David M.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuron (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Snider, B. Joy</au><au>Holtzman, David M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease</atitle><jtitle>Neuron (Cambridge, Mass.)</jtitle><date>2021-10-20</date><risdate>2021</risdate><volume>109</volume><issue>20</issue><spage>3199</spage><epage>3202</epage><pages>3199-3202</pages><issn>0896-6273</issn><eissn>1097-4199</eissn><abstract>The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.
The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, Snider and Holtzman discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.neuron.2021.08.026</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0896-6273 |
| ispartof | Neuron (Cambridge, Mass.), 2021-10, Vol.109 (20), p.3199-3202 |
| issn | 0896-6273 1097-4199 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2573438309 |
| source | Cell Press Free Archives; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals |
| subjects | Alzheimer’s disease clinical trials COVID-19 translational neuroscience |
| title | Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A02%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20COVID-19%20on%20preclinical%20and%20clinical%20research%20in%20neurology:%20Examples%20from%20research%20on%20neurodegeneration%20and%20Alzheimer%E2%80%99s%20disease&rft.jtitle=Neuron%20(Cambridge,%20Mass.)&rft.au=Snider,%20B.%20Joy&rft.date=2021-10-20&rft.volume=109&rft.issue=20&rft.spage=3199&rft.epage=3202&rft.pages=3199-3202&rft.issn=0896-6273&rft.eissn=1097-4199&rft_id=info:doi/10.1016/j.neuron.2021.08.026&rft_dat=%3Cproquest_cross%3E2573438309%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2573438309&rft_id=info:pmid/&rft_els_id=S0896627321006231&rfr_iscdi=true |